You haven't searched anything yet.
Description
Director-Clinical Quality & Risk Management
Transforming what patients can expect from cancer therapy takes passion and a strong dedicated team. When you join ADC Therapeutics, you will join a group of talented people who share this mission.
Why ADC Therapeutics
ADC Therapeutics (NYSE): is a commercial, global leader and pioneer in the field of antibody-drug conjugates (ADCs) with a constantly expanding technology toolbox. We are experts in the lifecycle of ADCs – starting with creation all the way through to commercialization. We have a robust pipeline of ADCS in clinical trials for both hematologic and solid tumor cancers. Our CD-19-directed ADC for relapsed/refractory non-Hodgkin lymphoma, ZYNLONTA® (loncastuxamab tesirine lpyl) has been approved in the United States and has also received European Commission approval. ZYNLONTA® is also being evaluated in combination with other anti-cancer therapeutics to determine if it has potential to treat an even broader range of patients. We consist of nearly 300 dedicated employees, all focused-on patient care and driven by purpose, who carry out our mission in a flexible work environment. If you’re interested in making a difference in the lives of patients worldwide with a team of like-minded colleagues, come join us on our journey!
To learn more about ADC Therapeutics, please visit us at https://adctherapeutics.com/ and follow us on LinkedIn.
Position Overview:
The position is responsible for implementation and management of ADCT’s system to manage quality throughout all stages of clinical trials and will report to the Vice President of Clinical Operations within the Chief Medical Officer (CMO) organization. The position supports design and implementation of efficient clinical trial protocols including tools and procedures for trial conduct (including data collection and management). This position will act as process owner for core compliance systems supporting clinical trials, such as Quality Risk Management, Issue Management, and risk-based Oversight. The individual in this position is responsible for the state of Good Clinical Practices (GCP) Sponsor Inspection Readiness for early and late phase clinical trials. This position will conduct quarterly meetings to review trends and risks with the CMO Leadership Team members to continuously improve the system and process.
Job Responsibilities:
Requirements
Qualifications:
ADC Therapeutics is proud to be an Affirmative Action/EEO Employer. EOE Minorities/Females/Protected Veterans/Disabled. We are committed to building diverse teams and fostering an inclusive, professional, and respectful work environment where employees are empowered for success.
Attention: Search firms/Third-party recruitment agencies
The People team manages the recruiting for all positions at ADC Therapeutics. We will only accept résumés from a search agency/recruiter if we have a signed agreement in place and we have formally requested your help on a specific role. Forwarding unsolicited resumes on behalf of potential candidates and/or vendor engagement requests to ADC Therapeutics hiring managers is strictly prohibited. Unsolicited résumés sent to ADCT will be considered property of ADCT. We will not be responsible for any fees associated should we hire from unsolicited résumés. Please send all emails and requests to recruiting@adctherapeutics.com.
Full Time
$198k-242k (estimate)
05/18/2024
07/14/2024